Literature DB >> 2477515

Control of extraneural metastasis of a primary intracranial nongerminomatous germ-cell tumor. Case report.

J Watterson1, J R Priest.   

Abstract

Primary intracranial germ-cell tumors are infrequently occurring neoplasms which most often arise in the pineal or sellar regions. Germinomas are seen more frequently than nongerminomatous germ-cell tumors; they are often curable with radiotherapeutic approaches, or with chemotherapy in the rare instance of extraneural metastasis. Nongerminomatous germ-cell tumors are relatively radioresistant and when extraneural metastasis has occurred, they have been fatal in all of the 32 previously reported cases. The case of a 14-year-old girl with a mixed malignant germ-cell tumor arising in the pineal region is reported. Extraneural metastasis to the lung developed 12 months after whole-brain radiotherapy was completed. She was treated with etoposide (VP-16), high-dose cisplatin, vinblastine, and bleomycin and is currently without evidence of disease 46 months postmetastasis.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2477515     DOI: 10.3171/jns.1989.71.4.0601

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  4 in total

1.  Improved prognosis of intracranial non-germinoma germ cell tumors with multimodality therapy.

Authors:  P L Robertson; R C DaRosso; J C Allen
Journal:  J Neurooncol       Date:  1997-03       Impact factor: 4.130

2.  Differences still exist in the approach to the diagnosis and management of pineal lesions.

Authors:  S Senan
Journal:  Acta Neurochir (Wien)       Date:  1993       Impact factor: 2.216

Review 3.  Chemotherapy for intramedullary spinal cord tumors.

Authors:  C Balmaceda
Journal:  J Neurooncol       Date:  2000-05       Impact factor: 4.130

4.  Hematogenous extraneural metastasis of the germinomatous component of a pineal mixed germ cell tumor.

Authors:  Megumi Asanuma; Tatsuro Aoyama; Keiichi Sakai; Koji Asano; Tsuyoshi Uehara; Kazuhiro Hongo
Journal:  Brain Tumor Pathol       Date:  2012-10       Impact factor: 3.298

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.